Literature DB >> 16702455

Delayed enhancement MR imaging: utility in myocardial assessment.

Jens Vogel-Claussen1, Carlos E Rochitte, Katherine C Wu, Ihab R Kamel, Thomas K Foo, João A C Lima, David A Bluemke.   

Abstract

Use of magnetic resonance (MR) imaging for diagnosis of cardiac diseases and treatment monitoring is expanding. Delayed myocardial enhancement MR imaging is performed after administration of paramagnetic contrast agents and is used for a growing number of clinical applications. This technique was developed primarily for characterization of myocardial scarring after myocardial infarction. On delayed enhancement MR images, scarring or fibrosis appears as an area of high signal intensity that is typically subendocardial or transmural in a coronary artery distribution. However, delayed myocardial enhancement is not specific for myocardial infarction and can occur in a variety of other disorders, such as inflammatory or infectious diseases of the myocardium, cardiomyopathy, cardiac neoplasms, and congenital or genetic cardiac conditions, as well as after cardiac interventions. In nonischemic myocardial disease, the delayed enhancement usually does not occur in a coronary artery distribution and is often midwall rather than subendocardial or transmural. Therefore, the patient's clinical history is critical in the evaluation of delayed myocardial enhancement MR images. Copyright RSNA, 2006.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16702455     DOI: 10.1148/rg.263055047

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  47 in total

1.  Evaluation of carcinoid heart disease using delayed enhancement imaging.

Authors:  M Hrabak-Paar; R Stern-Padovan
Journal:  Ir J Med Sci       Date:  2010-12-12       Impact factor: 1.568

Review 2.  Delayed Myocardial Enhancement in Cardiac Magnetic Resonance Imaging.

Authors:  Arie Franco; Saeed Javidi; Stefan G Ruehm
Journal:  J Radiol Case Rep       Date:  2015-06-30

Review 3.  [Cardiac MR imaging in arrhythmogenic heart diseases].

Authors:  C K Böhm; T Papavassiliu; D J Dinter; S J Diehl; M Borggrefe; K W Neff
Journal:  Radiologe       Date:  2007-04       Impact factor: 0.635

4.  Utility of endomyocardial biopsy guided by delayed enhancement areas on magnetic resonance imaging in the diagnosis of cardiac sarcoidosis.

Authors:  B Borchert; T Lawrenz; M Bartelsmeier; S Röthemeyer; H Kuhn; C Stellbrink
Journal:  Clin Res Cardiol       Date:  2007-08-21       Impact factor: 5.460

5.  Novel MRI of mediastinal masses: internal differentiation of a thymoma and lymphoma with T1 and T2 mapping.

Authors:  Tanvi Karnik; Rhiannon McBean; Graeme Hart; Katrina Newbigin
Journal:  BMJ Case Rep       Date:  2018-04-07

6.  Automatic regional analysis of myocardial native T1 values: left ventricle segmentation and AHA parcellations.

Authors:  Hsiao-Hui Huang; Chun-Yu Huang; Chiao-Ning Chen; Yun-Wen Wang; Teng-Yi Huang
Journal:  Int J Cardiovasc Imaging       Date:  2017-07-21       Impact factor: 2.357

7.  Novel cardiac magnetic resonance biomarkers: native T1 and extracellular volume myocardial mapping.

Authors:  Paola Maria Cannaò; Luisa Altabella; Marcello Petrini; Marco Alì; Francesco Secchi; Francesco Sardanelli
Journal:  Eur Heart J Suppl       Date:  2016-04-29       Impact factor: 1.803

Review 8.  Differentiation of myocardial scar from potential pitfalls and artefacts in delayed enhancement MRI.

Authors:  E B Turkbey; M S Nacif; R A Noureldin; C T Sibley; S Liu; J A C Lima; D A Bluemke
Journal:  Br J Radiol       Date:  2012-11       Impact factor: 3.039

9.  The role of first-pass perfusion deficit in the detection of cardiac subendocardial manifestation in patients with autoimmune vasculitis.

Authors:  Alexander Pfeil; Gabriele Lehmann; Joachim Böttcher; Gunter Wolf; Andreas Hansch
Journal:  Rheumatol Int       Date:  2012-01-03       Impact factor: 2.631

10.  Delayed enhancement cardiac magnetic resonance imaging reveals typical patterns of myocardial injury in patients with various forms of non-ischemic heart disease.

Authors:  Steffen Bohl; Ralf Wassmuth; Hassan Abdel-Aty; André Rudolph; Daniel Messroghli; Rainer Dietz; Jeanette Schulz-Menger
Journal:  Int J Cardiovasc Imaging       Date:  2008-03-16       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.